The effect of minimally modified LDL (MM-LDL) on the ability of large vessel endothelial cells (EC) to interact with monocytes and neutrophils was examined. These LDL preparations, obtained by storage or by mild iron oxidation, were indistinguishable from native LDL to the LDL receptor and were not recognized by the scavenger receptor. Treatment of EC with as little as 0.12 micrograms/ml MM-LDL caused a significant increase in the production of chemotactic factor for monocytes (sevenfold) and increased monocyte binding (three-to fivefold). Monocyte binding was maximal after 4 h of EC exposure to MM-LDL, persisted for 48 h, and was inhibited by cycloheximide. In contrast, neutrophil binding was not increased after 1-24 h of exposure. Activity in the MM-LDL preparations was found primarily in the polar lipid fraction. MM-LDL was toxic for EC from one rabbit but not toxic for the cells from another rabbit or any human umbilical vein EC. The resistant cells became sensitive when incubated with lipoprotein in the presence of cycloheximide, whereas the sensitive strain became resistant when preincubated with sublethal concentrations of MM-LDL. We conclude that exposure of EC to sublethal levels of MM-LDL enhances monocyte endothelial interactions and induces resistance to the toxic effects of MM-LDL.
Introduction
Oxidized lipoproteins have been found to be present in atherosclerotic plaques (1, 2) , and products of oxidation have been seen in early and late lesions in Watanabe heritable hyperlipidemic (WHHL) rabbits (3, 4) . These lipoproteins have also been reported to be present in the blood of humans and experimental animals at risk to develop lesions (5) (6) (7) . There is increasing evidence that oxidized lipoproteins may play an important role in atherogenesis, since development of lesions can be reduced by treatment of WHHL rabbits with potent antioxi-dothelium is seen in areas of predilection in cholesterol-fed animals, and it is in these areas that lesions first develop (10) . Previous studies have shown that LDL tends to accumulate in these areas and that the LDL residence time is increased ( 12) ; this increase might allow for cellular oxidation of the LDL. Other studies have shown that LDL can be oxidized by endothelium (13, 14) , smooth muscle cells (13, 15) , and macrophages in culture (16) . The mechanism by which LDL is oxidized in the vessel wall in vivo is not known, but it is clear that it must occur in the presence of at least some plasma transferrin, ceruloplasmin, and vitamin E. Several mechanisms have been suggested that would be facilitated by a long residence time in the vessel wall and involve direct contact of LDL with surrounding cells (17) . In early lesions the amount of oxidation would be relatively small since the subendothelial space at this stage is mainly acellular as compared with the fatty streak where highly oxidized LDL has been found (3, 4) . In the present study we have examined whether treatment of endothelial cells (EC)' in culture with minimally modified LDL (MM-LDL; 2-5 nmol thiobarbituric acid-reactive substance (TBARS)/mg cholesterol) increased binding of monocytes and production of monocyte chemotactic factor. The effect on monocyte endothelial interactions was compared with the effect on neutrophil endothelial interactions. In addition, the toxicity of MM-LDL was examined.
Methods
Cell preparation. Rabbit aortic EC (RAEC) at passages 6-17 and human umbilical vein (HUV) EC at passages 1-4 were used (18) . For these studies monocytes were obtained by a modification of the Recalde method (19). In brief, with this method citrated plasma is mixed with plasmagel and red blood cells allowed to sediment. A pellet of leukocytes is obtained by centrifugation at 600 g for 10 min, and these leukocytes are incubated in a slightly hypertonic solution for -30 min at 37°C. During this time the lymphocytes become more dense, whereas the monocytes do not. The monocytes are separated from lymphocytes using Ficoll-Hypaque. The mononuclear cell band contains -75% monocytes and 25% lymphocytes. It is this preparation that was used directly for the present studies. Although these preparations contained 25% lymphocytes and we routinely had only 15% lymphocytes in our preparations of elutriated monocytes, similar results were found with the use of monocytes obtained by elutriation for the response to EC chemotactic factor ( 19) and for monocyte binding (data not shown). The modified Recalde method has the advantages of being rapid and not involving adherence of monocytes, which may cause activation. Neutrophils were obtained by a Ficoll-Hypaque separation followed by a dextran sedimentation (20) . The human monocyte cell line THP-I (ATCC TIB202; American Type Culture Collection, Rockville, MD) was also used as a source of monocyte-like cells.
Lipoprotein preparation and analysis. LDL was isolated by density gradient centrifugation of serum and stored in phosphate-buffered 0.15 M NaCl containing 0.01% EDTA (buffer B). MM-LDL was obtained by storage of LDL at 4VC for 3-6 mo in plastic tubes. Iron-oxidized (Fe-ox) LDL (5 nmol TBARS/mg cholesterol) was prepared by previously described methods (21) . In several cases stored and freshly isolated LDL from the same individual were compared. Cholesterol-a epoxide (C-epox), prepared as described previously (22), was added to freshly isolated LDL preparations as follows: 20 jl Cepox (1 mg/ml in ethanol) was added to I mg of LDL in buffer B; the mixture was incubated at 370C for I h with occasional gentle mixing.
MM-LDL was separated into lipid and aqueous portions using chloroform methanol extraction (23), and neutral lipids were separated using diol extraction columns according to previously described methods (24) (Analytichem International, Inc., Harbor City, CA). The separated lipids were added to the cells as liposomes obtained by extrusion (25) . For the neutral lipids exogenous dipalymitoyl phosphatidylcholine (PC), at a ratio of 6 Adhesion assay. For adhesion studies EC were cultured in 48-well dishes in media containing 5% calf serum, with or without native LDL, or MM-LDL, and incubated for the stated times at 370C. Some cells were placed in medium containing LPS (1 gg/ml) for 4 h. Adhesion assays were carried out as described by Pawlowski et al. (27) . The wells, containing EC, were rinsed three times with serum-free medium, and 2 X l05 monocytes, or neutrophils in Dulbecco's modified Eagles medium containing 1% heat-inactivated serum, were added to each well. After I h the nonadherent leukocytes were rinsed offand the wells were fixed with 1% glutaraldehyde. The number of attached leukocytes was counted in each of 20 Chemotactic factor production. For studies of chemotactic factor production, EC were placed in medium containing 1% heat-inactivated fetal bovine serum with or without lipoprotein for 24 h. The medium was then collected and tested for chemotactic activity in a Neuroprobe chamber (Neuroprobe, Bethesda, MD) as described previously (18) . Positive controls using the chemotactic peptide FMLP and negative control medium (medium that was not exposed to EC) were run simultaneously with the test samples. Approximately three cells/high power field (HPF) were seen in the negative controls and -35 cells/HPF were seen in cells containing the positive controls. Assays for products of lipid peroxidation. TBARS were measured using methods previously described (28) . Hydroperoxides were determined on a lipid extract of the lipoproteins using the method of Asakawa and Matsushita (29) . Lipid was extracted with 5 vol of ethyl acetate containing 0.1% acetic acid, followed by 5 vol of methylene chloride. The organic solvents were pooled and removed by drying under nitrogen and the residue was tested for peroxide. The data are expressed as the nanomole equivalents of iodate. C-epox levels were measured by gas chromatography using a 30-m by 0.53-mm DB-1 column (J & W Scientific, Folsom, CA) (30) . Chromatographic conditions were as follows: the initial column temperature was 1 80'C, and the temperature was programmed at 16'C/min to a final temperature of 290'C; the total run time was 35 min with a helium flow rate of 10.5 ml/min; and the detector temperature was 300'C.
Lipoprotein degradation. MM-LDL, malondialdehyde-treated LDL (MDA-LDL), and freshly isolated LDL were iodinated and cellular degradation was measured after 4 h as described previously (31) .
For competition studies 10 20 ,gg/ml LPS (data not shown). MM-LDL in the present studies was active at 0.12 ug/ml, which could contain no more than 3 pg/ml of LPS, so that LPS did not account for our findings. We next compared the levels of TBARS, hydroperoxide, and C-epox in the MM-LDL preparations (obtained by storage) with that found in freshly isolated LDL. MM-LDL preparations had 1.5-2-fold higher levels of TBARS, 1.5-fold higher hydroperoxide, and 4-fold the level of C-epox compared with that of freshly isolated LDL (Fig. 1) . The rate of degradation of MM-LDL was comparable to that of LDL, but MDA-LDL degradation was approximately threefold higher ( Fig. 2 A) . These results suggest that MM-LDL was taken up by the LDL receptor. This suggestion was strengthened by the observation that LDL but not MDA-LDL suppressed uptake of MM-LDL (Fig. 2 B) . Cross-competition studies confirmed that MM-LDL inhibited for uptake of LDL but not MDA-LDL (data not shown).
Chemotaxis. Treatment of RAEC for 24 h with MM-LDL at 1 ,g/ml, stimulated chemotactic factor production by EC sevenfold (Fig. 3) . Treatment of RAEC with concentrations up to 100 gg/ml LDL did not increase chemotactic factor production. Medium containing lipoprotein, but not exposed to EC, was not chemotactic. In some studies concentrations as low as 0.05 jug/ml of MM-LDL caused a significant stimulation of chemotactic factor production, and stimulation at higher concentrations was linearly related to the dose of MM-LDL (Fig.  4) . The medium from EC treated with MM-LDL had no chemotactic activity for neutrophils (control 3+2, MM-LDL 3±1 cells/HPF).
Adhesion. A 24-h pretreatment of RAEC with MM-LDL at 5 ,ug/ml (but not LDL at concentrations up to 100 Ag/ml) induced a threefold increase in the adhesion of monocytes to EC. The magnitude of the increase was similar to that seen after a 4-h pretreatment with LPS (1 ng/ml) (Fig. 5) . Neutrophil adhesion was not stimulated by MM-LDL under the same conditions, but was stimulated by LPS (Fig. 5) (Fig. 7) . Neutrophil adhesion was not stimulated by MM-LDL at any time from 1 to 24 h (data not shown). The increased binding of monocytes was markedly reduced by treating the culture with 1 ug/ml of cycloheximide for 2 h before the addition of the MM-LDL, suggesting that protein synthesis was necessary for the full induction of monocyte adhesion (Fig. 8) .
To obtain further evidence that oxidation of the MM-LDL was responsible for the increased monocyte binding, several preparations of freshly isolated LDL were minimally oxidized using an iron-dependent peroxidizing system (5 nmol TBARS/mg cholesterol) and their effect on monocyte binding was determined. This MM-LDL prepared by Fe-ox at a concentration of 5-10 ,tg/ml had an effect comparable to that of stored MM-LDL at 1 Ag/ml (untreated, 230+15; MM-LDL, 1,650±87; Fe-ox, 1,963± 120).
The experiments in Fig. 9 were performed to determine the active component in MM-LDL inducing adherence. The activity was present in the organic phase of a chloroform methanol extract and was found in the charged lipids of this phase.
These polar lipids at 10 jig/ml gave a comparable activity to the whole MM-LDL particle at 3 ztg/ml. Examination of two preparations of MM-LDL using TLC showed that the polar lipid fraction contained large amounts of lyso PC as compared with freshly isolated LDL (freshly isolated, PC/lyso PC 4.5/1; MM-LDL, 1/1). Lyso PC is a potentially active component that has been shown by others to be chemotactic for monocytes (32) .
Since a major oxidation product in MM-LDL was C-epox, the effect on monocyte binding of freshly isolated LDL to which C-epox was added (epox-LDL) was determined. For these studies C-epox was added to LDL, the LDL was dialyzed, and the level of retained C-epox was measured. RAEC were then exposed for 4 h to 10-1,000 ng/ml of C-epox incorporated into LDL or 10 ng/ml of MM-LDL and monocyte binding was compared with that seen with native LDL. Binding was found to be 307±41, 2,157±141, 287+25, 445+60, and 1,265±111 cpm/well for EC exposed to native LDL, MM-LDL (10 ng/ml), and C-epox-LDL at 10, 100, and 1,000 ng/ml, respectively. These results suggest that C-epox alone could not be responsible for the sevenfold increase in binding seen with MM-LDL. However, at 100-fold higher C-epox levels (1,000 ng/ml) the C-epox-LDL increased binding threefold.
Toxicity. The effect on cell detachment of MM-LDL for two strains of RAEC at passage 11 and cells from six different isolates of HUV at passage 3 were examined (Fig. 10) . In nonserum medium or in medium containing 5% FCS (data not shown), MM-LDL was toxic for one strain of RAEC with an LD50 of 20 Ag/ml, but was nontoxic for another strain of 40 jig/ml of MM-LDL for 24 h proved to be resistant to the higher concentration after preexposure to the lower sublethal concentration (Fig. 1 1) . In addition, resistant cells were found to be sensitive to the toxic effects ofMM-LDL when incubated in the presence of cycloheximide ( MM-LDL (jg/ml) Figure 4 . Dose-response curve of the effect of MM-LDL on chemotactic factor production. These studies were performed as for Fig for monocytes not neutrophils, suggesting that an endothelial protein other than ELAM-I may be involved. The polar fraction and hence a phospholipid-associated component of the MM-LDL appears to be most active in inducing monocyte binding, although some effects of C-epox at a high concentration were also seen. Peroxidation of phospholipids in oxidized LDL has previously been observed both in vivo and in vitro (4, 35) . Cholesterol oxidation readily takes place in phospholipid-rich preparations (23). Moreover, cholesterol oxides are reported to be elevated in the serum of hypercholesterolemic patients to a level of 5 Rabbit cells from strain I (Fig. 10) We propose that at an early stage before fatty streak formation, MM-LDL may be active in stimulating EC to recruit monocytes. Cells from different individuals may respond differently to this agent. Once the fatty streak has been established, with large numbers of macrophages and possibly smooth muscle cells present, there is a high potential for greater LDL modification such as malondialdehyde formation. It is at this stage that the highly modified lipoproteins studied by others (41, 15) , along with the chemotactic factors produced by smooth muscle cells and macrophages (42) (43) (44) , may play a major role in sustaining the monocyte migration into the vessel wall.
